- Home
- BFRG vs XAIR Comparison
BFRG vs XAIR Comparison
Compare BFRG & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BFRG | XAIR |
|---|---|---|
| Founded | 2017 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2M | 10.5M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | BFRG | XAIR |
|---|---|---|
| Price | $0.72 | $1.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $11.00 |
| AVG Volume (30 Days) | 1.5M | ★ 21.5M |
| Earning Date | 11-14-2025 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $116,670.00 | ★ $5,802,000.00 |
| Revenue This Year | N/A | $127.85 |
| Revenue Next Year | N/A | $165.47 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 147.74 |
| 52 Week Low | $0.65 | $0.67 |
| 52 Week High | $4.84 | $10.40 |
Technical Indicators
Market Signals| Indicator | BFRG | XAIR |
|---|---|---|
| Relative Strength Index (RSI) | 34.12 | 62.87 |
| Support Level | $0.65 | $0.84 |
| Resistance Level | $1.05 | $2.66 |
| Average True Range (ATR) | 0.08 | 0.24 |
| MACD | -0.01 | 0.14 |
| Stochastic Oscillator | 18.50 | 52.69 |
Price Performance
Historical ComparisonAbout BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.